Jason J. LeBlanc, Canada

Nova Scotia Health Authority (NSHA) Microbiology

Presenter Of 3 Presentations

Author Of 6 Presentations

MOLECULAR IDENTIFICATION AND SEROTYPING OF PNEUMOCOCCAL NASOPHARYNGEAL CARRIAGE (NPC) VS CULTURE AND QUELLUNG SEROTYPING IN HEALTHY CHILDREN: A CALGARY S. PNEUMONIAE EPIDEMIOLOGY RESEARCH (CASPER) STUDY (ID 348)

RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH HOSPITALIZATION OF COMMUNITY ACQUIRED PNEUMONIA (CAP): A SERIOUS OUTCOMES SURVEILLANCE (SOS) NETWORK STUDY. (ID 754)

Session Name
Population Sciences - Epidemiology, Economics, and Mathematical Modelling

Abstract

Background

Almost 20% of CAP cases require hospitalization. This study aimed to assess the cost of hospitalization due to CAP to inform delivery of preventative strategies such as vaccination programs.

Methods

The SOS Network study has collected data from 40 tertiary care sites across Canada regarding the clinical characteristics, outcomes information, and resource use of CAP cases from 2010 to 2015. The cost per case was calculated by linking resource costs to resource use frequency for each case. Resource costs included direct and overhead costs.

Results

8,802 CAP admissions were enrolled, and 17.5% were admitted to ICU. The mean age of patients was 69.6 years. The overall length of hospitalization was 10.9 days (95% CI: 10.6, 11.2) and length of ICU stay was 9.0 days (95% CI: 8.4, 9.5). The average cost per case was $138 (95% CI: $129, $147) prior to admission, $14,354 (95% CI: $13,966, $14,743) during admission, and $455 (95% CI: $393, $516) 30-days following admission. The total cost per case was $14,947 (95% CI: $14,553, $15,341).

Conclusions

The cost of CAP hospitalization was higher than previous estimates, and driven mostly by the length of stay. Such data is important for accurate cost effectiveness estimates of prevention programs.

Hide